A wholly owned subsidiary of Provista Life Sciences, Provista Diagnostics Inc is a molecular diagnostics company focused on the development and commercialization of diagnostic, prognostic and predictive tests for early oncology-related disease state recognition and detection purposes. Near term development and commercialization efforts have been particularly focused on women's cancers such as breast and ovarian cancer, as well as early detection testing for lung cancer. Provista also offers diagnostic testing and clinical laboratory services to the pharmaceutical and biotechnology industries through Provista Companion Diagnostics, a CLIA-accredited and GLP capable laboratory, licensed in 49 states to perform human clinical testing. In June 2019, Provista Diagnostics was acquired by Georgia-basedAscenda BioSciences.
